Drugs · acquisition-cost intelligence
Oxycodone Hydrochloride
Oxycodone· ingredient oxycodone· OXYCODONE HYDROCHLORIDE 10 mg/1; OXYCODONE HYDROCHLORIDE 15 mg/1; OXYCODONE HYDROCHLORIDE 20 mg/1; OXYCODONE HYDROCHLORIDE 30 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.23670
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 9 weeks.
2025-07-012026-05-27
Same-ingredient options by acquisition cost
Other oxycodone products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| oxycodone hydrochloride | $0.07841 | −$0.15830 |
| Oxycodone Hydrochloride | $0.41767 | +$0.18100 |
| Oxycodone hydrochloride | $2.13 | +$1.89 |
Medicare Part D coverage · CY2026
On 326 plan formularies · typical tier 3
Prior auth 1% · Step therapy 0% · Quantity limit 90% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.